Drawing for CB

USPTO serial 79276007

CB

Reviewed by CopyMark Law Group

Reg. 6110263Status 739Renewal
Filing date
Status date
Registration date
Jul 28, 2020
Examiner
FATHY, DOMINIC
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with CB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609United States

Goods and services

ClassDescriptionStatusFirst use
005[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; ] pharmaceutical preparations acting on the central nervous system [ ; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 12, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 12, 2026NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Feb 12, 2026C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Feb 9, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 6, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Jul 28, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 6, 2020FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 18, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 17, 2020FIMPFINAL DISPOSITION PROCESSED—
Oct 28, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 28, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 12, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 12, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 26, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 21, 2020RFNTREFUSAL PROCESSED BY IB—
Mar 13, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 12, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 12, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 9, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 9, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 9, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 9, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 9, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 9, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 3, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 3, 2020RFRRREFUSAL PROCESSED BY MPU—
Feb 8, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 7, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2020DOCKASSIGNED TO EXAMINER—
Jan 21, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 17, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 16, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jan 9, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance